4th Quarter - Report

HOOPER, LUNDY & BOOKMAN, P.C. for ROCHE DIAGNOSTICS CORPORATION

Period 4th Quarter 2020 Filed Jan 20, 2021 Signed by Debra Jones

Official filing
Firm
HOOPER, LUNDY & BOOKMAN, P.C.
Client
ROCHE DIAGNOSTICS CORPORATION
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020 (HR 6102/S 3404).

LobbyistCovered position, as disclosed
LISA LAYMAN SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6102 (116th)

Health Issues HCR

Policies related to diagnostic testing and diagnostic testing capacity; The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020 (HR 6102/S 3404); ), Consolidated Appropriations Act, 2021 (H.R. 133).

LobbyistCovered position, as disclosed
LISA LAYMAN SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6102 (116th), H.R. 133 (116th)

Medicare/Medicaid MMM

Medicare payment for clinical laboratories and diagnostic tests.

LobbyistCovered position, as disclosed
LISA LAYMAN SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.